Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis
Academic Article
Publication Date:
2016
Iris type:
1.1 Articolo in rivista
List of contributors:
Merlini, Giampaolo; Lousada, I.; Ando, Y.; Dispenzieri, A.; Gertz, M. A.; Grogan, M.; Maurer, M. S.; Sanchorawala, V.; Wechalekar, A.; Palladini, Giovanni; Comenzo, R. L.
Published in: